lecture 12 Flashcards

- immunological tolerance -- central tolerance -- peripheral tolerance - when tolerance fails -- autoimmune diseases -- allergy

1
Q

What is immunological tolerance?

A
  • key feature of the adaptive immune system
  • self/non-self discrimination
  • occurs in both T cells and B cells
  • specific unresponsiveness to an antigen following prior exposure to that antigen
    • self antigen
    • non-self antigen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Who discovered acquired immunological tolerance? How?

A
  • Sir Frank Macfarlane Burnet and Sir Peter Medawar
  • nobel prize in physiology or medicine in 1960
  • showed that the neonatal period is fundamental in the development of tolerance and that it can be produced
  • in mice - introduced strain B graft into adult strain A mice –> rejected
  • introduced strain B graft into strain A mice that had been injected with spleen cells from strain B during the neonatal period –> accepted
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Why is tolerance important?

A
  • specificity of the adaptive immune system critical
  • results from the processes that drive both T cell and B cell diversity during lymphocyte development
    • 10^11 different antibody (B cells) and TCR specificities
  • self-reactivity can occur and result in host damage
  • immune system is in balance between immunity and tolerance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are key factors determining whether an immune response (or tolerance) occurs?

A
  • [Ag]
  • avidity
  • costimuli
  • timing and duration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are T cell tolerance mechanisms?

A

Central tolerance

  • occurs in the thymus
  • positive/negative selection of immature T cells

Peripheral tolerance

  • occurs in peripheral tissues
  • ‘regulatory’ responses involving mature T cells
  • anergy - cell is there but receives no costimulation
  • inducing apoptosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is something B cells can do in the development of central tolerance?

A
  • change receptors: receptor editing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What happens in T cell selection in the thymus?

A
  • occurs as the T cell matures
  • dependent on affinity of TCR binding to self antigen
  • in the initial phase positive selection
  • T cells are selected for based on their recognition of antigen both self and non-self, in the context of MHC and the TCR
  • cells where the affinity for the antigen is very low, they undergo apoptosis by neglect - signalling too low, considered to be an unwanted immune response so they die
  • if the affinity is too high they are negatively selected
  • it is only a small fraction of maturing T cells, that have intermediate affinity for antigen in the context of MHC, that survive
  • these cells enter the periphery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How is peripheral tolerance generated?

A
  • self reactive T cells that enter the circulation are regulated by peripheral tolerance
  • mechanisms include:
    • clonal anergy (lack of costimulation)
    • ignorance (do not encounter their antigen) (e.g. proteins in the eye are immune privileged)
    • suppression by cytokines (e.g. TGF-beta)
    • specific regulation (Treg induction)
    • negative regulation (engagement of CTLA4)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How do B cells generate tolerance?

A
  • occurs in the bone marrow
  • needs T cell tolerance to be intact
  • self-reactive B cells can be:
    • deleted when high affinity for antigen
    • made anergic when antigen is soluble and at high concentration
    • ignorance when lack of T cell help or low antigen concentration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What happens when tolerance fails?

A
  • autoimmune disease can occur when mechanisms of immunological tolerance break down
  • “Horror autotoxicus” (Ehrlich)
  • can be caused by:
    • acquisition of T cell help
    • molecular mimicry
    • failure of regulatory networks
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is autoimmunity?

A
  • immune response against self-antigen
  • involve both self-reactive T and B cells
  • presence of autoreactive lymphocytes does not necessarily result in autoimmunity
    • naturally occurring autoantibodies (thought to be involved in mopping up debris etc)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the pathogenesis of autoimmunity?

A
  • multifactorial
  • genetic susceptibility
  • environmental influence e.g. infection, smoking, drugs
  • lead to the presence of an autoantigen
  • combined lead to autoimmunedisease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is molecular mimicry?

A
  • similar/identical epitopes between microbe and host
  • could be linear or conformational
  • important when host antigen has important biological function
  • e.g. streptococcal protein and bacterial endocarditis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the Treg function in autoimmunity?

A
  • major mechanism in the development of autoimmunity
  • contact and contactless
  • IL-10 and TGF-beta important cytokines in suppressing a response
  • also inhibition via cell-cell contact through TCR
  • key feature is to render cells non-responsive
  • if that fails either genetically or through some environmental factor you can get loss of regulation and those self-reactive T cells in the periphery that might normally be kept in check can be left and expand and become pathogenic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are Milgrom and Witebsky’s criteria for autoimmune diseases?

A
  • lymphocytic infiltration of the target organ
  • presence of circulating autoantibodies and/or cellular immunity against the target organ
  • identification of the specific antigen(s)
  • production of humoral and/or cellular autoimmune response in animals sensitised by autologous antigen
  • close association with other autoimmune disorders
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the spectrum of autoimmune diseases?

A
  • from very organ specific (hashimoto thyroiditis) to widespread (systemic lupus erythematosus)
  • also insulin-dependent diabetes mellitus
17
Q

What are pathogenic autoantibodies?

A
  • key autoantibodies associated with autoimmune diseases
  • non-organ specific
    • anti-DNA antibodies: SLE
    • anti-cytoskeleton antibodies
  • organ specific
    • anti-glomerular basement membrane: SLE, Goodpasture’s syndrome
    • anti-thyroglobulin antibodies: thyroiditis
    • anti-myelin basic protein: multiple sclerosis
    • anti-mitochondrial antibodies: primary biliary cirrhosis
18
Q

How do we diagnose autoantibodies?

A
  • autoantibody patterns

characteristic of non-organ specific autoimmune diseases

  • actin-binding protein (actinin): AI hepatitis, Rheumatoid arthritis, very intense bright spots = accumulation
  • intermediate filament (vimentin): Sjogren’s syndrome
  • Cartilage (Glycosaminoglycans): rheumatoid arthritis

characteristic of organ-specific autoimmune diseases

  • kidney, anti-mitochondrial Ab, primary biliary cirrhosis
  • parietal cell - stomach intrinsic factor autoimmune gastritis
  • kidney - glomerular basement membrane, goodpasture’s syndrome
19
Q

What is diabetes?

A
  • group of diseases affecting insulin production and/or function
  • organ-specific autoimmune disease (type 1)
  • targets the islets of langerhans cells of the pancreas – important for insulin secretion
  • secondary damage to kidneys, eyes, nerves, blood vessels
  • onset from first year of life to older adulthood
20
Q

What are the types of diabetes?

A

Type 1 diabetes (5-10% of cases)

  • pancreatic beta cell destruction
  • insulin deficiency

Type 2 diabetes (90-95% of cases)

  • relative insulin deficiency
  • inadequate production or peripheral resistance to insulin action

Other types

  • gestational diabetes
  • latent autoimmune diabetes in adults (LADA)
  • maturity onset diabetes of youth (MODA)
21
Q

What is LADA?

A
  • latent autoimmune diabetes in adults
  • a form of autoimmune diabetes which is diagnosed in individuals who are older than the usual age of onset of type 1 diabetes
  • also known as “late-onset autoimmune diabetes of adulthood”, “slow onset type 1” diabetes, and sometimes also “Type 1.5”
  • LADA patients often thought to have type 2 diabetes due to their age at diagnosis
  • patients usually aged >25 years
  • clinical presentation “masquerading” as non-obese type 2 diabetes
  • initial control achieved with diet alone or diet and oral hypoglycaemic agents
  • insulin dependency occurs within months but can take 10 years of more
  • other features of type 1 diabetes
    • low fasting and post-glucagon stimulated C-peptide
    • HLA susceptibility alleles
    • JCA+
    • GADA
22
Q

What is the pathogenesis of type 1 diabetes?

A

Genetic

  • HLA-DR3/4
  • HLA-DQ8
  • CTLA-4
  • Insulin
  • CD25

Environmental
- infections esp viral

not vaccine

  • gradual failure of T cell tolerance:
    • interaction between susceptibility and protection genes
    • evidence of insulitis
    • over diabetes

all in conjunction with immune dysregulation, environmental triggers, autoantibody appearance etc

  • progressive accumulation of inflammatory cell infiltrate
  • CD4 and CD8 T cells
23
Q

What are the immunological events in diabetes?

A

Failure of T cell tolerance

  • defective clonal deletion (central)
  • regulatory response altered (peripheral)

Prior to clinical symptoms

  • autoreactive T cells become activated
  • autoantibodies are produced
  • destroy islets of Langerhans in pancreas
  • occur over many years until nearly all beta cells affected
24
Q

What are the autoantibodies in diabetes?

A

Major autoantibodies are reactive to 4 islet autoantigens (termed islet cell autoantibodies, ICA)

  • insulinoma-associated antigen-2 (ICA512)
  • insulin (micro-insulin autoantibodies, IAA)
  • glutamic acid decarboxylase 65 (GAD65) (most common in general)
  • zinc transporter 8 (ZnT8)

Important role for B cells in pathogenesis

25
Q

Give a summary of type 1 diabetes.

A

Clinical

  • onset: usually childhood and adolescence
  • normal weight or weight loss preceding diagnosis
  • progressive decrease in insulin levels
  • circulating islet autoantibodies (anti-insulin, anti-GAD, anti-ICA512)
  • diabetic ketoacidosis in absence of insulin therapy
Genetics 
- major linkage to MHC class I and II genes; also linked to polymorphisms in CTLA4 and PTPN22, and insulin gene VNTRs 

Pathogenesis
- dysfunction in regulatory T cells (Tregs) leading to breakdown in self-tolerance to islet auto-antigens

Pathology

  • insulitis (inflammatory infiltrate of T cells and macrophages)
  • Beta-cell depletion, islet atrophy
26
Q

What is systemic lupus erythematosus?

A
  • multi-system chronic autoimmune disease
    • remitting and relapsing
  • acute or insidious in onset
  • many organs are affected
    • skin
    • kidney
27
Q

What are the criteria for SLE classification?

A
  1. malar rash - very common, wolf-like feature across cheekbones
  2. discoid rash
  3. photosensitivity - sensitivity to sunlight
  4. oral ulcers
  5. arthritis
  6. serositis
  7. renal disorder
  8. neurologic disorder
  9. hematologic disorder
  10. immunological disorder
  11. antinuclear antibody - critical, characteristic diagnostic feature - over 90% of cases
28
Q

What do antibodies in SLE target?

A
  • diverse structures
  • typical non-organ specific autoimmune disease
  • autoantibodies detected against:
    • nuclear antigens
    • cytoplasmic antigens
    • cell-surface antigens
  • pathogenic in nature
  • diagnostic feature is the presence of antinuclear autoantibodies
  • antibodies to Sm antigen and dsDNA are diagnostic of SLE
  • others include:
    • anti-lymphocyte
    • anti-platelet
    • antiphospholipid
29
Q

What are anti-nuclear autoantibody patterns?

A
  • Speckled Sm, RNPs
  • peripheral dsDNA
  • nucleolar RNA
  • homogeneous chromatin, histones
30
Q

Whatis the pathogenesis of SLE?

A
  • susceptibility genes
  • external triggers (e.g. UV radiation)
  • failure of self tolerance
  • release of self-reactive antigens
31
Q

What is the pathological mechanism of SLE?

A
  • type III hypersensitivity (immune complex)
    • DNA-anti DNA complex
  • Affected sites are kidneys and small blood vessels
    • glomerulonephritis
    • skin involvement
32
Q

What is type III hypersensitivity?

A
  • immune complexes formed mainly in organs where blood is filtered (e.g. kidneys, joints)
  • acute inflammatory response
  • IgG and IgM (complement fixing)
  • phagocytosis
33
Q

What are the hallmark lesions in SLE?

A
  • glomerulonephritis: mesangium and capillary wall

- skin lesions: dermoepidermal junction

34
Q

What is the clinical course of SLE?

A
  • disease course can be variable
  • 90% survival (5 years); 80% 10 years
  • most common cause of death is renal failure
  • treatment:
    • corticosteroids
    • immunosuppressants